See more : FNCB Bancorp, Inc. (FNCB) Income Statement Analysis – Financial Results
Complete financial analysis of The Valens Company Inc. (VLNS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Valens Company Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Gwangju Shinsegae. Co. ,Ltd. (037710.KS) Income Statement Analysis – Financial Results
- Seven Utilities and Power Public Company Limited (7UP.BK) Income Statement Analysis – Financial Results
- Enersize Oyj (ENERS.ST) Income Statement Analysis – Financial Results
- Mennica Polska S.A. (MNC.WA) Income Statement Analysis – Financial Results
- Air New Zealand Limited (AIZ.AX) Income Statement Analysis – Financial Results
The Valens Company Inc. (VLNS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thevalenscompany.com
About The Valens Company Inc.
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.
The Valens Company continues to gain recreational market share in the six months to April
The Valens Company announces separation of chair and CEO roles; appoints Andrew Cockwell as new chair of the board
The Valens Company to Participate in Upcoming Investor Conferences
It's 420 Holiday Week! These 9 Cannabis Stocks Are on Fire
The Valens Company Inc. (VLNS) CEO Tyler Robson on Q1 2022 Results - Earnings Call Transcript
The Valens Company sees fiscal 1Q net revenue rise by 26.1% as its diversified cannabis business lines gain traction
The Valens Company "a meaningful buying opportunity" at current levels, says M Partners
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2022
Valens Company updates shareholders on financing rationale and integration initiatives as it continues on its path to profitability
The Valens Company closes previously announced bought deal public offering of units for total gross proceeds of approximately C$32.3M
Source: https://incomestatements.info
Category: Stock Reports